(continued 
from 
Why Are Prescription Drugs So Expensive?)
How profitable are the COVID-19 vaccines?
Each dose of Pfizer's COVID-19 vaccine costs "76 pence" (source), equal to $1.00, to manufacture. Pfizer's Chief Financial Officer (CFO) Frank D'Amelio told investors during the company's February 2, 2021 earnings call that once Pfizer's vaccine has gained market acceptance, he expects it to eventually be priced at "150, 175 dollars per dose" (source).
Roughly 60%, 25% and 15% of the world's 7.8 billion people live in low-, middle- and high-income countries, respectively. If the eventual gross profit per dose for all COVID-19 vaccines is conservatively estimated to be $14, $59 and $149 from low-, middle- and high-income countries, respectively, and if everyone gets 2 doses per year, the combined gross profit for the vaccine makers will be $710 billion ($710,000,000,000) per year:
Countries  | 
		Percent of Total  | 
		Billion People  | 
		Profit /Dose  | 
		Doses /Year  | 
		Gross Profit /Year  | 
	
| Low Income | 60% | 4.68 | $14 | 2 | $131 billion | 
| Middle Income | 25% | 1.95 | $59 | 2 | $230 billion | 
| High Income | 15% | 1.17 | $149 | 2 | $349 billion | 
| TOTAL | 100% | 7.80 | $710 billion | ||
If the vaccine makers spend another $2 per dose to distribute the 15.6 billion doses, bribe government officials and doctors, etc. (see Big Pharma Corruption), their combined net profit will be $679 billion per year, which at a price-to-earnings (P/E) ratio of 15, will raise their combined market valuation by $10.2 trillion ($10,200,000,000,000). This figure will rise even higher if they manage to establish their mRNA vaccine technology as the platform for selling other recurrent "vaccines."
"For the love of money is a root of all kinds of evil, 
for which some have strayed from the faith in their greediness, and pierced 
themselves through with many sorrows."
1 Timothy 6:10